160 related articles for article (PubMed ID: 16585076)
1. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.
Brøgger J; Steen VM; Eiken HG; Gulsvik A; Bakke P
Eur Respir J; 2006 Apr; 27(4):682-8. PubMed ID: 16585076
[TBL] [Abstract][Full Text] [Related]
2. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
3. Microsomal epoxide hydrolase gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in the Tunisian population.
Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Chibani JB; Khelil AH
Genet Test Mol Biomarkers; 2010 Dec; 14(6):857-63. PubMed ID: 20932192
[TBL] [Abstract][Full Text] [Related]
4. Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing.
Jiang L; He B; Zhao MW; Ning LD; Li XY; Yao WZ
Chin Med J (Engl); 2005 Apr; 118(7):541-7. PubMed ID: 15820084
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD.
Chappell S; Daly L; Morgan K; Guetta-Baranes T; Roca J; Rabinovich R; Lotya J; Millar AB; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra PS; Miniati M; Monti S; O'Connor CM; Kalsheker N
Eur Respir J; 2008 Oct; 32(4):931-7. PubMed ID: 18614560
[TBL] [Abstract][Full Text] [Related]
6. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample.
Matheson MC; Raven J; Walters EH; Abramson MJ; Ellis JA
Hum Biol; 2006 Dec; 78(6):705-17. PubMed ID: 17564249
[TBL] [Abstract][Full Text] [Related]
7. EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.
Lee J; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Jan; 37(1):18-25. PubMed ID: 20516053
[TBL] [Abstract][Full Text] [Related]
8. EPHX1 Y113H polymorphism is associated with increased risk of chronic obstructive pulmonary disease in Kazakhstan population.
Akparova A; Abdrakhmanova B; Banerjee N; Bersimbaev R
Mutat Res Genet Toxicol Environ Mutagen; 2017 Apr; 816-817():1-6. PubMed ID: 28464990
[TBL] [Abstract][Full Text] [Related]
9. Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease.
Xiao D; Wang C; Du MJ; Pang BS; Zhang HY; Xiao B; Liu JZ; Weng XZ; Su L; Christiani DC
Chin Med J (Engl); 2004 May; 117(5):661-7. PubMed ID: 15161530
[TBL] [Abstract][Full Text] [Related]
10. [Association between polymorphisms in the microsomal epoxide hydrolase (mEH) gene and chronic obstructive pulmonary disease].
Xiao D; Wang C; Du MJ; Pang BS; Zhang HY; Xiao B; Liu JZ; Weng XZ; Su L; Christiani DC
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1782-6. PubMed ID: 14642084
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
12. Exploration of association between EPHX1 and chronic obstructive pulmonary disease on the basis of combined data mining.
An L; Xia H; Zhou P; Hua L
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173271
[TBL] [Abstract][Full Text] [Related]
13. No effects of EPHX1 polymorphisms on the level or change of FEV1 in the general population.
Siedlinski M; Postma DS; Smit HA; Boezen HM
Eur Respir J; 2009 Feb; 33(2):446-9. PubMed ID: 19181923
[No Abstract] [Full Text] [Related]
14. Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers.
Tanaka G; Sandford AJ; Burkett K; Connett JE; Anthonisen NR; Paré PD; He JQ
Eur Respir J; 2007 Jan; 29(1):34-41. PubMed ID: 16971410
[TBL] [Abstract][Full Text] [Related]
15. Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD.
Chappell S; Daly L; Morgan K; Baranes TG; Roca J; Rabinovich R; Millar A; Donnelly SC; Keatings V; Macnee W; Stolk J; Hiemstra PS; Miniati M; Monti S; O'Connor CM; Kalsheker N
Eur Respir J; 2007 Oct; 30(4):810-2. PubMed ID: 17906092
[No Abstract] [Full Text] [Related]
16. A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers.
Young RP; Hopkins RJ; Hay BA; Epton MJ; Mills GD; Black PN; Gardner HD; Sullivan R; Gamble GD
Postgrad Med J; 2009 Oct; 85(1008):515-24. PubMed ID: 19789190
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response.
Chen CZ; Wang RH; Lee CH; Lin CC; Chang HY; Hsiue TR
J Formos Med Assoc; 2011 Nov; 110(11):685-9. PubMed ID: 22118311
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.
Hu G; Shi Z; Hu J; Zou G; Peng G; Ran P
Respirology; 2008 Nov; 13(6):837-50. PubMed ID: 18811882
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand.
Chierakul N; Wongwisutikul P; Vejbaesya S; Chotvilaiwan K
Respirology; 2005 Jan; 10(1):36-9. PubMed ID: 15691236
[TBL] [Abstract][Full Text] [Related]
20. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.
Hersh CP; Demeo DL; Lange C; Litonjua AA; Reilly JJ; Kwiatkowski D; Laird N; Sylvia JS; Sparrow D; Speizer FE; Weiss ST; Silverman EK
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):71-8. PubMed ID: 15817713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
